These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 36796670)
1. PLA2G2A Ge W; Yue M; Lin R; Zhou T; Xu H; Wang Y; Mao T; Li S; Wu X; Zhang X; Wang Y; Ma J; Wang Y; Xue S; Shentu D; Cui J; Wang L Cancer Lett; 2023 Apr; 558():216095. PubMed ID: 36796670 [TBL] [Abstract][Full Text] [Related]
2. Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator in Pancreatic Ductal Adenocarcinoma. Zhang J; Wang YF; Wu B; Zhong ZX; Wang KX; Yang LQ; Wang YQ; Li YQ; Gao J; Li ZS Curr Mol Med; 2017; 17(10):689-698. PubMed ID: 29521231 [TBL] [Abstract][Full Text] [Related]
3. C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer. Sasaki K; Takano S; Tomizawa S; Miyahara Y; Furukawa K; Takayashiki T; Kuboki S; Takada M; Ohtsuka M J Exp Clin Cancer Res; 2021 Jun; 40(1):212. PubMed ID: 34167573 [TBL] [Abstract][Full Text] [Related]
4. Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry. Brouwer TP; de Vries NL; Abdelaal T; Krog RT; Li Z; Ruano D; Fariña A; Lelieveldt BPF; Morreau H; Bonsing BA; Vahrmeijer AL; Koning F; de Miranda NFCC J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793870 [TBL] [Abstract][Full Text] [Related]
5. Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma. Ene-Obong A; Clear AJ; Watt J; Wang J; Fatah R; Riches JC; Marshall JF; Chin-Aleong J; Chelala C; Gribben JG; Ramsay AG; Kocher HM Gastroenterology; 2013 Nov; 145(5):1121-32. PubMed ID: 23891972 [TBL] [Abstract][Full Text] [Related]
6. IL-17A-producing CD8 Picard FSR; Lutz V; Brichkina A; Neuhaus F; Ruckenbrod T; Hupfer A; Raifer H; Klein M; Bopp T; Pfefferle PI; Savai R; Prinz I; Waisman A; Moos S; Chang HD; Heinrich S; Bartsch DK; Buchholz M; Singh S; Tu M; Klein L; Bauer C; Liefke R; Burchert A; Chung HR; Mayer P; Gress TM; Lauth M; Gaida M; Huber M Gut; 2023 Aug; 72(8):1510-1522. PubMed ID: 36759154 [TBL] [Abstract][Full Text] [Related]
7. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma. Fitzgerald AA; Wang S; Agarwal V; Marcisak EF; Zuo A; Jablonski SA; Loth M; Fertig EJ; MacDougall J; Zhukovsky E; Trivedi S; Bhatia D; O'Neill V; Weiner LM J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34737215 [TBL] [Abstract][Full Text] [Related]
8. PLA2G2A Phospholipase Promotes Fatty Acid Synthesis and Energy Metabolism in Pancreatic Cancer Cells with Zhang M; Xiang R; Glorieux C; Huang P Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233022 [TBL] [Abstract][Full Text] [Related]
9. Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response. Wang Y; Liang Y; Xu H; Zhang X; Mao T; Cui J; Yao J; Wang Y; Jiao F; Xiao X; Hu J; Xia Q; Zhang X; Wang X; Sun Y; Fu D; Shen L; Xu X; Xue J; Wang L Cell Discov; 2021 May; 7(1):36. PubMed ID: 34035226 [TBL] [Abstract][Full Text] [Related]
10. The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic Cancer. Stouten I; van Montfoort N; Hawinkels LJAC Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240052 [TBL] [Abstract][Full Text] [Related]
11. Prosaposin, tumor-secreted protein, promotes pancreatic cancer progression by decreasing tumor-infiltrating lymphocytes. Miyahara Y; Takano S; Sogawa K; Tomizawa S; Furukawa K; Takayashiki T; Kuboki S; Ohtsuka M Cancer Sci; 2022 Aug; 113(8):2548-2559. PubMed ID: 35633503 [TBL] [Abstract][Full Text] [Related]
13. Poor clinical outcomes and immunoevasive contexture in CD161 Chen Q; Yin H; Jiang Z; He T; Xie Y; Mao W; Han J; Liu S; Lou W; Wu W; Habib JR; Yu J; Liu L; Pu N J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38531664 [TBL] [Abstract][Full Text] [Related]
14. Perineural Invasion Reprograms the Immune Microenvironment through Cholinergic Signaling in Pancreatic Ductal Adenocarcinoma. Yang MW; Tao LY; Jiang YS; Yang JY; Huo YM; Liu DJ; Li J; Fu XL; He R; Lin C; Liu W; Zhang JF; Hua R; Li Q; Jiang SH; Hu LP; Tian GA; Zhang XX; Niu N; Lu P; Shi J; Xiao GG; Wang LW; Xue J; Zhang ZG; Sun YW Cancer Res; 2020 May; 80(10):1991-2003. PubMed ID: 32098780 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of insulin-like growth factors increases production of CXCL9/10 by macrophages and fibroblasts and facilitates CD8 Freeman P; Bellomo G; Ireland L; Abudula M; Luckett T; Oberst M; Stafferton R; Ghaneh P; Halloran C; Schmid MC; Mielgo A Front Immunol; 2024; 15():1382538. PubMed ID: 39165364 [TBL] [Abstract][Full Text] [Related]
16. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma. Tang Y; Xu X; Guo S; Zhang C; Tang Y; Tian Y; Ni B; Lu B; Wang H PLoS One; 2014; 9(3):e91551. PubMed ID: 24637664 [TBL] [Abstract][Full Text] [Related]
17. CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell response in the syngeneic mouse model. Wang R; Chen J; Wang W; Zhao Z; Wang H; Liu S; Li F; Wan Y; Yin J; Wang R; Li Y; Zhang C; Zhang H; Cao Y J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35086948 [TBL] [Abstract][Full Text] [Related]
18. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer. Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616 [TBL] [Abstract][Full Text] [Related]